BMJ Open Respiratory Research (Sep 2020)
Retrospective analysis of high flow nasal therapy in COVID-19-related moderate-to-severe hypoxaemic respiratory failure
- Rohit Gupta,
- Andrew Gangemi,
- Huaqing Zhao,
- Gerard Criner,
- Maulin Patel,
- Robert Marron,
- Junad Chowdhury,
- Ibraheem Yousef,
- Matthew Zheng,
- Nicole Mills,
- Lauren Tragesser,
- Julie Giurintano,
- Matthew Gordon,
- Parth Rali,
- Gilbert D'Alonso,
- David Fleece,
- Nicole Patlakh
Affiliations
- Rohit Gupta
- Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA
- Andrew Gangemi
- Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA
- Huaqing Zhao
- Department of Clinical Sciences, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA
- Gerard Criner
- Respiratory Medicine, Temple University, Philadelphia, Pennsylvania, USA
- Maulin Patel
- Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA
- Robert Marron
- Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA
- Junad Chowdhury
- Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA
- Ibraheem Yousef
- Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA
- Matthew Zheng
- Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA
- Nicole Mills
- 5Cambridge University Hospitals NHS Foundation Trust, UK
- Lauren Tragesser
- Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA
- Julie Giurintano
- Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA
- Matthew Gordon
- Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA
- Parth Rali
- Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA
- Gilbert D'Alonso
- Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA
- David Fleece
- 5 Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA
- Nicole Patlakh
- Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA
- DOI
- https://doi.org/10.1136/bmjresp-2020-000650
- Journal volume & issue
-
Vol. 7,
no. 1
Abstract
Conclusion HFNT use is associated with a reduction in the rate of invasive mechanical ventilation and overall mortality in patients with COVID-19 infection.
